ארצות הברית - אנגלית - NLM (National Library of Medicine)

bimeda, inc. - chloramphenicol (unii: 66974fr9q1) (chloramphenicol - unii:66974fr9q1) - chloramphenicol 250 mg - indications : chloramphenicol tablets are recommended for oral treatment of the following conditions in dogs: - bacterial pulmonary infections caused by susceptible microorganisms such as: staphylococcus aureus , streptococcus pyogenes and brucella bronchiseptica . - infections of the urinary tract caused by susceptible microorganisms such as: escherichia coli , proteus vulgaris , corynebacterium renale , streptococcus spp., and hemolytic staphylococcus . - enteritis caused by susceptible microorganisms such as: e. coli , proteus spp., salmonella spp., and pseudomonas spp. - infections associated with canine distemper caused by susceptible microorganisms such as: b. bronchiseptica , e. coli , p. aeruginosa , proteus spp., shigella spp. and neisseria catarrhalis . additional adjunctive therapy should be used when indicated. most susceptible infectious disease organisms will respond to chloramphenicol therapy in three to five days when the recommended dosage regimen is followed. if no response to chloram

מלטה - אנגלית - Medicines Authority

ursapharm arzeneitmittel gmbh industriestrasse, 66129 saarbrucken, germany - chloramphenicol - eye ointment - chloramphenicol 10 mg/g - ophthalmologicals

מלטה - אנגלית - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - chloramphenicol - powder for injection - chloramphenicol 1 g - antibacterials for systemic use

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

viatris limited - ceftriaxone sodium 1.079 g equivalent to 1 g ceftriaxone (anhydrous) - powder for injection - 1 g - active: ceftriaxone sodium 1.079 g equivalent to 1 g ceftriaxone (anhydrous) - infections caused by pathogens sensitive to ceftriaxone e.g.: - sepsis; - meningitis; - abdominal infections (peritonitis, infections of the biliary and gastrointestinal tracts); - infections of the bones, joints, soft tissue, skin and of wounds; - infections in patients with impaired defence mechanisms; - renal and urinary tract infections; - respiratory tract infections, particularly pneumonia, and ear, nose and throat infections; - genital infections, including gonorrhoea. - perioperative prophylaxis of infections.

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - ceftriaxone sodium 1.193 g (present as 1.193g ceftriaxone sodium*3.5h2o. eq 1.0793g of ceft. sodium anh or 1g ceftriaxone anh) - powder for injection - 1 g - active: ceftriaxone sodium 1.193 g (present as 1.193g ceftriaxone sodium*3.5h2o. eq 1.0793g of ceft. sodium anh or 1g ceftriaxone anh) - infections caused by pathogens sensitive to ceftriaxone e.g.: · sepsis; · meningitis; · abdominal infections (peritonitis, infections of the biliary and gastrointestinal tracts); · infections of the bones, joints, soft tissue, skin and of wounds; · infections in patients with impaired defence mechanisms; · renal and urinary tract infections; · respiratory tract infections, particularly pneumonia, and ear, nose and throat infections; · genital infections, including gonorrhoea. · perioperative prophylaxis of infections.

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - chloramphenicol, quantity: 5 mg/ml - eye drops - excipient ingredients: phenylmercuric nitrate; borax; boric acid; water for injections - for the treatment of bacterial conjunctivitis. for use under medical supervision only in the treatment of other superficial ocular infections caused by chloramphenicol sensitive organisms.

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - chloramphenicol, quantity: 5 mg/ml - eye drops - excipient ingredients: water for injections; boric acid; borax; phenylmercuric nitrate - for the treatment of bacterial conjunctivitis. for use under medical supervision only in the treatment of other superficial ocular infections caused by chloramphenicol sensitive organisms.

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - ceftazidime pentahydrate, quantity: 1175 mg (equivalent: ceftazidime, qty 1000 mg) - injection, powder for - excipient ingredients: sodium carbonate - ceftazidime for injection is indicated for the treatment of single and mixed infections caused by susceptible aerobic organisms with suspected or documented resistance to other antimicrobials, but not to ceftazidime, and as an alternative to aminoglycosides in pseudomonal infection in patients in whom aminoglycoside toxicity is a cause for concern and other pseudomonal antibiotics cannot be used. ,indications include the following:,severe infections in general: ,for example: septicaemia including neonatal sepsis, bacteraemia; and in patients in intensive care units with specific problems, e.g., infected burns.,respiratory tract infections: ,for example: pneumonia, broncho-pneumonia, infected pleurisy, infected bronchiectasis and bronchitis.,severe ear, nose and throat infections: ,for example: otitis media, mastoiditis.,urinary tract infections: ,for example: acute and chronic pyelonephritis, pyelitis, cystitis, urethritis (bacterial only), and infections associated with bladder and renal stones.,skin and soft tissue infections: ,for example, erysipelas, abscesses, cellulitis, infected burns and wounds, mastitis.,gastrointestinal and abdominal infections: ,for example: intra-abdominal abscesses, enterocolitis.,bone and joint infections: ,for example: osteitis, osteomyelitis, septic arthritis, infected bursitis.

הממלכה המאוחדת - אנגלית - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - chloramphenicol - eye ointment - 10mg/1gram

הממלכה המאוחדת - אנגלית - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - chloramphenicol - eye ointment - 10mg/1gram